Asthma, airflow limitation and mortality risk in the general population

European Respiratory Journal

Volumn 45, Issue 2, 2015, Pages 338-346

  Huang, Shuang ^a,b   Vasquez, Monica M ^a,b   Halonen, Marilyn ^a   Martinez, Fernando D ^a   Guerra, Stefano ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; RISK ASSESSMENT; ARIZONA; EOSINOPHILIA; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK FACTOR; SPIROMETRY; VERY ELDERLY; VITAL CAPACITY; YOUNG ADULT;

IMMUNOGLOBULIN E;

ADULT; AGED; AGED, 80 AND OVER; ARIZONA; ASTHMA; COHORT STUDIES; EOSINOPHILIA; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; VITAL CAPACITY; YOUNG ADULT;

EID: 84961317493     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00108514     Document Type: Article

References (34)

1. Soriano JB, Davis KJ, Coleman B, et al. The proportional venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003;124:474-481.
2. Viegi G, Matteelli G, Angino A, et al. The proportional venn diagram of obstructive lung disease in the Italian general population. Chest 2004;126:1093-1101.
3. Guerra S, Martinez FD. Epidemiology of the origins of airflow limitation in asthma. Proc Am Thorac Soc 2009;6:707-711.
4. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
5. Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med 2008;102:1473-1482.
6. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008;63:761-767.
7. Piras B, Miravitlles M. The overlap phenotype: the (missing) link between asthma and COPD. Multidiscip Respir Med 2012;7:8.
8. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it?. Thorax 2009;64:728-735.
9. Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008;134:14-19.
10. Blanchette CM, Gutierrez B, Ory C, et al. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare advantage population. J Manag Care Pharm 2008;14:176-185.
11. Blanchette CM, Broder M, Ory C, et al. Cost and utilization of COPD and asthma among insured adults in the US. Curr Med Res Opin 2009;25:1385-1392.
12. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009;34:812-818.
13. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127.
14. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
15. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-931.
16. Hospers JJ, Schouten JP, Weiss ST, et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. Am J Respir Crit Care Med 1999;160:1869-1874.
17. Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313-1317.
18. Silverstein MD, Reed CE, O'Connell EJ, et al. Long-term survival of a cohort of community residents with asthma. N Engl J Med 1994;331:1537-1541.
19. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996;347:1285-1289.
20. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1, 075 outpatients with asthma. Chest 1995;108:10-15.
21. Panizza JA, James AL, Ryan G, et al. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006;36:773-780.
22. Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U. S. Population. COPD 2011;8:400-407.
23. Soriano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002;20:819-825.
24. Mapel DW, Nelson LS, Lydick E, et al. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. COPD 2007;4:127-134.
25. Mapel DW, Hurley JS, Roblin D, et al. Survival of COPD patients using inhaled corticosteroids and long-acting β-agonists. Respir Med 2006;100:595-609.
26. McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-1755.
27. Lebowitz MD, Knudson RJ, Burrows B. Tucson epidemiologic study of obstructive lung diseases. I: methodology and prevalence of disease. Am J Epidemiol 1975;102:137-152.
28. Knudson RJ, Slatin RC, Lebowitz MD, et al. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113:587-600.
29. Davis KB, Fisher L, Gillespie MJ, et al. A test of the national death index using the coronary artery surgery study (CASS). Control Clin Trials 1985;6:179-191.
30. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
31. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U. S. Population. Am J Respir Crit Care Med 1999;159:179-187.
32. Andersen PK, Geskus RB, de Witte T, et al. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-870.
33. Huovinen E, Kaprio J, Vesterinen E, et al. Mortality of adults with asthma: a prospective cohort study. Thorax 1997;52:49-54.
34. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-1314.